Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease

Recruiting N/A Interventional Study
Atheroscleroses, Coronary Atheroscleroses, Cerebral Atherosclerotic Ischemic Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
300 (estimated)
Sponsor
Vestre Viken Hospital Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide and in Norway. Approximately 50% of the patients admitted to hospitals with an acute ASCVD event has had a previous event. The high number of patients being readmitted to hospitals with new ASCVD events is to a large degree explained by poor control of established risk factors such as high L…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria (all the following): * Aged \>=18 years and signed informed consent and expected cooperation according to ICH/GCP and national/local regulations * Hospitalised with an planned or unplanned ASCVD event and/or established atherosclerosis * Access to a smartphone or tablet Exclusio…
Contacts

John Munkhaugen, MD, PhD

+4797524194

johmun@vestreviken.no

CONTACT